Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. November 08 2023 inter alia considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on September 30 2023 along with Limited Review Report issued by M/s. V Goswami & Co Statutory Auditors of the Company.Further please find enclosed Standalone and Consolidated Unaudited Financial Results Statement of Assets and Liabilities and Cash Flow Statement along with Limited Review Report for the quarter ended on September 30 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.comThe Board Meeting of the Company commenced at 03:30 PM and concluded at 04:40 PM.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
